Close

Celgene (CELG) PT Bumped to $206 at Citi

January 6, 2014 8:56 AM EST Send to a Friend
Citi raised its price target on Buy-rated Celgene (NASDAQ: CELG) from $204 to $206 as guidance is now ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login